FOLH1 and neoplasm: Still, the high renal excretion and bladder accumulation of all 68 Ga-labeled PSMA ligands of clinical use greatly hamper primary urothelial detection due to the very low tumor neovasculature PSMA uptake compared to the considerable urinary PSMA activity background.